Multidrug-resistant tuberculosis in patients for whom first-line treatment failed, Mongolia, 2010–2011

Emerging Infectious Diseases

Volumn 21, Issue 8, 2015, Pages 1451-1454

  Dobler, Claudia C ^a,b   Korver, Sarah ^c   Batbayar, Ochirbat ^c   Nyamdulam, Batiargal ^c   Oyuntsetseg, Sodnomdarjaa ^c   Tsolmon, Bold ^c   Surmaajav, Bazarragchaa ^c   Bayarjargal, Byambaa ^c   Marais, Ben J ^b,d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c National Centre for Communicable Diseases   (Mongolia)

^d University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; ARTICLE; DISEASE TRANSMISSION; DRUG SENSITIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONGOLIA; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDY; SPUTUM SMEAR; TREATMENT FAILURE; TREATMENT OUTCOME; CHILD; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; RISK; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; UTILIZATION;

ADOLESCENT; ADULT; CHILD; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MONGOLIA; RISK; SPUTUM; TREATMENT FAILURE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84937405758     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2108.141860     Document Type: Article

References (13)

1. Falzon D, Jaramillo E, Schünemann H, Arentz M, Bauer M, Bayona J, et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J. 2011;38:516-28.
2. Matthys F, Rigouts L, Sizaire V, Vezhnina N, Lecoq M, Golubeva V, et al. Outcomes after chemotherapy with WHO category II regimen in a population with high prevalence of drug resistant tuberculosis. PLoS ONE. 2009;4:e7954. http://dx.doi.org/ 10.1371/journal.pone.0007954
3. Seung KJ, Gelmanova IE, Peremitin GG, Golubchikova VT, Pavlova VE, Sirotkina OB, et al. The effect of initial drug resistance on treatment response and acquired drug resistance during standardized short-course chemotherapy for tuberculosis. Clin Infect Dis. 2004;39:1321-8. http://dx.doi.org/10.1086/425005
4. Saravia JC, Appleton SC, Rich ML, Sarria M, Bayona J, Becerra MC. Retreatment management strategies when first-line tuberculosis therapy fails. Int J Tuberc Lung Dis. 2005;9:421-9.
5. Han LL, Sloutsky A, Canales R, Naroditskaya V, Shin S, Seung K, et al. Acquisition of drug resistance in multidrug-resistant Mycobacterium tuberculosis during directly observed empiric retreatment with standardized regimens. Int J Tuberc Lung Dis. 2005;9:818-21.
6. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. Geneva: The Organization; 2010.
7. Siddiqi SH, Rüsch-Gerdes S. MGIT procedure manual. Geneva: Foundation for Innovative New Diagnostics [cited 2015 Jun 1]. http://www.finddiagnostics.org/export/sites/default/resource-centre/find_reports/pdfs/mgit_manual_nov_2007.pdf
8. Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT, et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ. 1963;29:565-78.
9. Marais BJ, Mlambo CK, Rastogi N, Zozio T, Duse AG, Victor TC, et al. Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa. J Clin Microbiol. 2013;51:1818-25. http://dx.doi.org/10.1128/JCM.00200-13
10. Sanchez-Padilla E, Merker M, Beckert P, Jochims F, Dlamini T, Kahn P, et al. Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland. N Engl J Med. 2015;372:1181-2. http://dx.doi.org/10.1056/NEJMc1413930
11. Tsogt G, Naranbat N, Buyankhisig B, Batkhuyag B, Fujiki A, Mori T. The nationwide tuberculosis drug resistance survey in Mongolia, 1999. Int J Tuberc Lung Dis. 2002; 6:289-94.
12. Buyankhishig B, Naranbat N, Mitarai S, Rieder HL. Nationwide survey of anti-tuberculosis drug resistance in Mongolia. Int J Tuberc Lung Dis. 2011;15:1201-5. http://dx.doi.org/10.5588/ ijtld.10.0594
13. Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, Masham S, et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis. 2013;13:529-39. http://dx.doi.org/10.1016/S1473-3099(13)70030-6